ウイルス学検体採取の世界市場：製品、検体、エンドユーザー別-2025-2030年予測

ウイルス学検体採取市場は、2023年に26億8,000万米ドルと評価され、2024年には33億1,000万米ドルに達すると予測され、CAGR 23.89％で成長し、2030年には120億5,000万米ドルに達すると予測されています。

ウイルス学検体採取市場は、綿棒、血液、尿、唾液など、ウイルス感染の診断に必要なサンプルを採取する役割によって定義されます。この市場は、パンデミックへの備えと日常的なウイルス学の両方において、正確な診断ツールが不可欠です。その用途は臨床診断、創薬から疫学調査まで多岐にわたり、病院、診断研究所、研究機関に影響を与えています。この分野の促進要因には、ウイルスアウトブレイクの増加、感染症に対する意識の高まり、収集手法の進歩などがあります。自動化、AI、保管・輸送技術の向上は大きなビジネスチャンスとなります。企業にとっては、これらの進歩を活用することで力強い成長が期待できます。サンプルの完全性を高め、デジタル診断プラットフォームを統合することに重点を置くことが推奨されます。成長機会とは裏腹に、市場成長は高コスト、厳しい規制の枠組み、検体の輸送と保管に伴う物流の複雑さといった課題に直面しています。これらを克服するために、企業はサプライチェーンの効率化を目指した費用対効果の高いイノベーションとパートナーシップを優先すべきです。

新たなビジネスチャンスは、特に資源に制約のある環境において、利便性と信頼性を提供する迅速検体採取キットの開発にあります。複雑なインフラの必要性を最小化するポータブル診断機器への投資も、市場プレイヤーを差別化できます。検体採取と包括的な診断サービスを結びつける遠隔医療とデジタルヘルス・ソリューションの役割も、開発の有望な道です。技術革新は、検体分析の可搬性、精度、スピードの向上に焦点を当てなければならないです。市場競争は激しく、急速に進化しているため、新技術や顧客ニーズへの絶え間ない適応が必要です。企業は、健康上の緊急事態に迅速に対応できるスケーラブルなソリューションに注力することで、世界のウイルス学的状況における自社の役割を確固たるものにすることができます。このような戦略的イノベーションと提携により、企業は現在の需要に対応できるだけでなく、将来の不測の課題にも効果的に対処できるようになります。

市場力学：急速に進化するウイルス学検体採取市場の主要市場インサイトを公開

ウイルス学検体採取市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ウイルス性疾患の流行と新しい病原体の出現
  • 献血数の増加
  • 検体採取の安全性を維持するために政府が定めたガイドライン
• 市場抑制要因
  • 検体採取、取り扱い、輸送の不適切な手順に関する懸念
• 市場機会
  • 官民機関からの旺盛な資金援助
  • 抗ウイルス治療薬の開発進展
• 市場の課題
  • ウイルス学検体採取技術の高コスト

ポーターの5つの力：ウイルス学検体採取市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、ウイルス学検体採取市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ウイルス学検体採取市場における外部からの影響の把握

外部マクロ環境要因は、ウイルス学検体採取市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ウイルス学検体採取市場における競合情勢の把握

ウイルス学検体採取市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスウイルス学検体採取市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ウイルス学検体採取市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ウイルス学検体採取市場における成功への道筋を描く

ウイルス学検体採取市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ウイルス性疾患の蔓延と新たな病原体の出現
    • 献血数の増加
    • 政府は検体採取の安全を維持するためのガイドラインを設定
  • 抑制要因
    • 収集、処理、輸送の手順が不十分であることに関する懸念
  • 機会
    • 公的機関および民間機関からの強力な資金
    • 抗ウイルス治療薬の開発の進歩
  • 課題
    • ウイルス学検体採取テクノロジーの高コスト
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ウイルス学検体採取市場：製品別

• 採血キット
• 検体採取チューブ
• 綿棒
• ウイルス輸送メディア

第7章 ウイルス学検体採取市場サンプル

• 血液サンプル
• 子宮頸部サンプル
• 鼻腔サンプル
• 鼻咽頭サンプル
• 口腔サンプル
• 喉のサンプル

第8章 ウイルス学検体採取市場：エンドユーザー別

• 診断センター
• 病院・クリニック

第9章 南北アメリカのウイルス学検体採取市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のウイルス学検体採取市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのウイルス学検体採取市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Element Materials Technology Group Limited
• Hardy Diagnostics
• HiMedia Laboratories, LLC
• LABORATORY ALLIANCE OF CENTRAL NEW YORK, LLC
• Laboratory Corporation of America Holdings
• Medical Wire & Equipment
• Merck KGaA
• Omega Bio-tek, Inc.
• PHARMIWEB.COM LIMITED
• Puritan Medical Products
• Quidel Corporation
• Thermo Fisher Scientific Inc.
• Trinity Biotech PLC

LIST OF FIGURES

• FIGURE 1. VIROLOGY SPECIMEN COLLECTION MARKET RESEARCH PROCESS
• FIGURE 2. VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. VIROLOGY SPECIMEN COLLECTION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. VIROLOGY SPECIMEN COLLECTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VIROLOGY SPECIMEN COLLECTION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VIROLOGY SPECIMEN COLLECTION MARKET DYNAMICS
• TABLE 7. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD COLLECTION KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CERVICAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ORAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. CANADA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. CANADA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 51. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. INDIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. INDIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 54. INDIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. ITALY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. ITALY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 106. ITALY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. POLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. POLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 118. POLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. QATAR VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. QATAR VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 121. QATAR VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. VIROLOGY SPECIMEN COLLECTION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 150. VIROLOGY SPECIMEN COLLECTION MARKET, FPNV POSITIONING MATRIX, 2023

The Virology Specimen Collection Market was valued at USD 2.68 billion in 2023, expected to reach USD 3.31 billion in 2024, and is projected to grow at a CAGR of 23.89%, to USD 12.05 billion by 2030.

The market for virology specimen collection is defined by its role in acquiring samples necessary for diagnosing viral infections, which include swabs, blood, urine, and saliva. This market is indispensable due to the critical need for accurate diagnostic tools in both pandemic preparedness and routine virology. Its applications range from clinical diagnostics and drug discovery to epidemiological research, impacting hospitals, diagnostic labs, and research institutes. Driving factors in this sector include the rise in viral outbreaks, heightened awareness about infectious diseases, and advancements in collection methodologies. The use of automation, AI, and improved storage and transport technologies presents significant opportunities. For businesses, tapping into these advancements can yield robust growth; a focus on enhancing sample integrity and integrating digital diagnostic platforms is advised. Despite opportunities, market growth faces challenges such as high costs, stringent regulatory frameworks, and logistical complexities associated with specimen transport and storage. To overcome these, businesses should prioritize cost-effective innovations and partnerships aimed at enhancing supply chain efficiency.

Emerging opportunities lie in developing rapid specimen collection kits that offer convenience and reliability, particularly in resource-constrained settings. Investing in portable diagnostic devices that minimize the need for complex infrastructure can also differentiate market players. The role of telemedicine and digital health solutions in linking specimen collection with comprehensive diagnostic services is another promising avenue for development. Innovation must focus on improving portability, accuracy, and speed of specimen analysis. The market is competitive and rapidly evolving, necessitating constant adaptation to new technologies and customer needs. Companies will benefit from focusing on scalable solutions that can swiftly respond to health emergencies, thus solidifying their role in the global virology landscape. These strategic innovations and collaborations will position businesses to not only meet current demands but also address unforeseen future challenges effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Virology Specimen Collection Market

The Virology Specimen Collection Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of viral diseases and emergence of newer pathogens
  • Growing number of blood donations
  • Government set guidelines to maintain safety of specimen collection
• Market Restraints
  • Concerns regarding inadequate procedures for collection, handling, transport
• Market Opportunities
  • Robust funding from the public and private agencies
  • Development progress in antiviral therapeutics
• Market Challenges
  • High cost of virology specimen collection technologies

Porter's Five Forces: A Strategic Tool for Navigating the Virology Specimen Collection Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Virology Specimen Collection Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Virology Specimen Collection Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Virology Specimen Collection Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Virology Specimen Collection Market

A detailed market share analysis in the Virology Specimen Collection Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Virology Specimen Collection Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Virology Specimen Collection Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Virology Specimen Collection Market

A strategic analysis of the Virology Specimen Collection Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Virology Specimen Collection Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Becton, Dickinson and Company, Element Materials Technology Group Limited, Hardy Diagnostics, HiMedia Laboratories, LLC, LABORATORY ALLIANCE OF CENTRAL NEW YORK, LLC, Laboratory Corporation of America Holdings, Medical Wire & Equipment, Merck KGaA, Omega Bio-tek, Inc., PHARMIWEB.COM LIMITED, Puritan Medical Products, Quidel Corporation, Thermo Fisher Scientific Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Virology Specimen Collection Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Blood Collection Kits, Specimen Collection Tubes, Swabs, and Viral Transport Media.
• Based on Sample, market is studied across Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Oral Samples, and Throat Samples.
• Based on End User, market is studied across Diagnostic Centers and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of viral diseases and emergence of newer pathogens
    • 5.1.1.2. Growing number of blood donations
    • 5.1.1.3. Government set guidelines to maintain safety of specimen collection
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns regarding inadequate procedures for collection, handling, transport
  • 5.1.3. Opportunities
    • 5.1.3.1. Robust funding from the public and private agencies
    • 5.1.3.2. Development progress in antiviral therapeutics
  • 5.1.4. Challenges
    • 5.1.4.1. High cost of virology specimen collection technologies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Virology Specimen Collection Market, by Product

• 6.1. Introduction
• 6.2. Blood Collection Kits
• 6.3. Specimen Collection Tubes
• 6.4. Swabs
• 6.5. Viral Transport Media

7. Virology Specimen Collection Market, by Sample

• 7.1. Introduction
• 7.2. Blood Samples
• 7.3. Cervical Samples
• 7.4. Nasal Samples
• 7.5. Nasopharyngeal Samples
• 7.6. Oral Samples
• 7.7. Throat Samples

8. Virology Specimen Collection Market, by End User

• 8.1. Introduction
• 8.2. Diagnostic Centers
• 8.3. Hospitals & Clinics

9. Americas Virology Specimen Collection Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Virology Specimen Collection Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Virology Specimen Collection Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Becton, Dickinson and Company
• 3. Element Materials Technology Group Limited
• 4. Hardy Diagnostics
• 5. HiMedia Laboratories, LLC
• 6. LABORATORY ALLIANCE OF CENTRAL NEW YORK, LLC
• 7. Laboratory Corporation of America Holdings
• 8. Medical Wire & Equipment
• 9. Merck KGaA
• 10. Omega Bio-tek, Inc.
• 11. PHARMIWEB.COM LIMITED
• 12. Puritan Medical Products
• 13. Quidel Corporation
• 14. Thermo Fisher Scientific Inc.
• 15. Trinity Biotech PLC